CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Deferred State and Local Income Tax Expense (Benefit)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Deferred State and Local Income Tax Expense (Benefit) of -$12.20 million for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-02-18
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. deferred state and local income tax expense (benefit) for fiscal 2025 was -$12.20M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. deferred state and local income tax expense (benefit) for fiscal 2024 was -$9.72M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. deferred state and local income tax expense (benefit) for fiscal 2023 was -$9.14M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. deferred state and local income tax expense (benefit) for fiscal 2022 was -$4.74M.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-27 | -$12.20M 10-K · filed 2026-02-18 |
| 2024-12-28 | -$9.72M 10-K · filed 2026-02-18 |
| 2023-12-30 | -$9.14M 10-K · filed 2026-02-18 |
| 2022-12-31 | -$4.74M 10-K · filed 2025-02-19 |
| 2021-12-25 | -$6.71M 10-K · filed 2024-02-14 |
| 2020-12-26 | -$4.39M 10-K · filed 2023-02-22 |
| 2019-12-28 | -$1.15M 10-K · filed 2022-02-16 |
| 2018-12-29 | $928.00K 10-K · filed 2021-02-17 |
| 2017-12-30 | $3.62M 10-K · filed 2020-02-11 |
| 2016-12-31 | -$31.00K 10-K · filed 2019-02-13 |
| 2015-12-26 | -$541.00K 10-K · filed 2018-02-13 |
| 2014-12-27 | $518.00K 10-K · filed 2017-02-14 |
| 2013-12-28 | $432.00K 10-K · filed 2016-02-12 |
| 2012-12-29 | $862.00K 10-K · filed 2015-02-17 |
| 2011-12-31 | $20.00K 10-K · filed 2014-02-25 |
| 2010-12-25 | -$3.25M 10-K · filed 2013-02-27 |
| 2009-12-26 | $1.54M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |